Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Cardiology
>
2020
>
48
>
7
Volume:
48
Issue:
7
1. Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19.
Page:565—566
2. Antithrombotic management of patients with atrial fibrillation and coronary artery disease: expert consensus document of Chinese Society of Cardiology.
Page:552—564
3. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19.
Page:567—571
4. Angiotensin-converting enzyme 2 and coronavirus: research update on pathogenesis of the infection induced by this indissoluble bond.
Page:539—545
5. 2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs.
Page:532—538
6. Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection:friend or foe?.
Page:527—531
7. Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics.
Page:587—592
8. Impact of drugs used for the treatment of 2019 novel coronavirus on cardiovascular system.
Page:546—551
9. Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results.
Page:580—586
10. Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients.
Page:572—579
11. Efficacy and safety of alirocumab versus ezetimibe in high cardiovascular risk Chinese patients with hyperlipidemia: ODYSSEY EAST Study-Chinese sub-population analysis.
Page:593—599
12. Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions.
Page:600—607
13. Thrombus detachment induced acute inferior myocardial infarction in a patient with atrial fibrillation complicating with occlusion of saphenous vein: a case report.
Page:608—609
14. Research progress on the circadian clock regulation in cardiovascular system and association between circadian clock regulation and cardiovascular diseases.
Page:610—615
15. Research progress on the role of STAT3 in cardiovascular diseases.
Page:616—620
16. Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm.
Page:621—625